List of Tables:
Table 1. Snapshot of North America CRISPR Gene Editing Market in Balanced Perspective, 2021-2031 18
Table 2. World Economic Outlook, 2021-2031 23
Table 3. Developing Roadmap of CRISPR Technology 27
Table 4. Private and Public Companies Investment in CRISPR Technology 28
Table 5. Comparison of CRISPR with Other Gene Editing Technologies 31
Table 6. World Health Spending by Region, $ bn, 2013-2020 34
Table 7. Main Product Trends and Market Opportunities in North America CRISPR Gene Editing Market 38
Table 8. North America CRISPR Gene Editing Market by Offering, 2021-2031, $ mn 46
Table 9. North America CRISPR Gene Editing Market: CRISPR Products by Type, 2021-2031, $ mn 49
Table 10. North America CRISPR Gene Editing Market: Kits & Enzymes by Type, 2021-2031, $ mn 50
Table 11. North America CRISPR Gene Editing Market: CRISPR Services by Type, 2021-2031, $ mn 57
Table 12. North America CRISPR Gene Editing Market by Application, 2021-2031, $ mn 63
Table 13. North America CRISPR Gene Editing Market: Biomedical Research & Therapy by Type, 2021-2031, $ mn 66
Table 14. North America CRISPR Gene Editing Market by End User, 2021-2031, $ mn 74
Table 15. North America CRISPR Gene Editing Market by Country, 2021-2031, $ mn 81
Table 16. U.S. CRISPR Gene Editing Market by Offering, 2021-2031, $ mn 85
Table 17. U.S. CRISPR Gene Editing Market by Application, 2021-2031, $ mn 85
Table 18. U.S. CRISPR Gene Editing Market by End User, 2021-2031, $ mn 85
Table 19. Canada CRISPR Gene Editing Market by Offering, 2021-2031, $ mn 87
Table 20. Canada CRISPR Gene Editing Market by Application, 2021-2031, $ mn 87
Table 21. Canada CRISPR Gene Editing Market by End User, 2021-2031, $ mn 87
Table 22. Mexico CRISPR Gene Editing Market by Offering, 2021-2031, $ mn 89
Table 23. Mexico CRISPR Gene Editing Market by Application, 2021-2031, $ mn 89
Table 24. Mexico CRISPR Gene Editing Market by End User, 2021-2031, $ mn 89
Table 25. Breakdown of World Market by Key Vendor, 2021, % 92
Table 26. Abcam, Inc.: Company Snapshot 95
Table 27. Abcam, Inc.: Business Segmentation 96
Table 28. Abcam, Inc.: Product Portfolio 96
LIST OF FIGURE
List of Figures:
Figure 1. Research Method Flow Chart 12
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation 15
Figure 3. North America Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2021-2031 17
Figure 4. North America CRISPR Gene Editing Market, 2021-2031, $ mn 19
Figure 5. Categories of CRISPR-Cas Systems 20
Figure 6. Impact of COVID-19 on Business 24
Figure 7. Primary Drivers and Impact Factors of North America CRISPR Gene Editing Market 26
Figure 8. Leading Causes of Death in the World, 2019-2020, million 32
Figure 9. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million 33
Figure 10. World Population 65 and Over, % of Total Population, 1950-2060 33
Figure 11. Primary Restraints and Impact Factors of North America CRISPR Gene Editing Market 35
Figure 12. Investment Opportunity Analysis 39
Figure 13. Porters Fiver Forces Analysis of North America CRISPR Gene Editing Market 42
Figure 14. Breakdown of North America CRISPR Gene Editing Market by Offering, 2021-2031, % of Revenue 47
Figure 15. North America Addressable Market Cap in 2022-2031 by Offering, Value ($ mn) and Share (%) 47
Figure 16. North America CRISPR Gene Editing Market by Offering: CRISPR Products, 2021-2031, $ mn 48
Figure 17. North America CRISPR Gene Editing Market by CRISPR Products: Kits & Enzymes, 2021-2031, $ mn 50
Figure 18. North America CRISPR Gene Editing Market by CRISPR Products: Databases & Libraries, 2021-2031, $ mn 51
Figure 19. North America CRISPR Gene Editing Market by CRISPR Products: Design Tools, 2021-2031, $ mn 52
Figure 20. North America CRISPR Gene Editing Market by CRISPR Products: Antibodies, 2021-2031, $ mn 53
Figure 21. North America CRISPR Gene Editing Market by CRISPR Products: CRISPR Plasmid & Vector, 2021-2031, $ mn 54
Figure 22. North America CRISPR Gene Editing Market by CRISPR Products: Other Products, 2021-2031, $ mn 55
Figure 23. North America CRISPR Gene Editing Market by Offering: CRISPR Services, 2021-2031, $ mn 56
Figure 24. North America CRISPR Gene Editing Market by CRISPR Services: gRNA Design & Vector Construction, 2021-2031, $ mn 58
Figure 25. North America CRISPR Gene Editing Market by CRISPR Services: Cell Line Engineering, 2021-2031, $ mn 59
Figure 26. North America CRISPR Gene Editing Market by CRISPR Services: Microbial Gene Editing, 2021-2031, $ mn 60
Figure 27. North America CRISPR Gene Editing Market by CRISPR Services: DNA Synthesis, 2021-2031, $ mn 61
Figure 28. North America CRISPR Gene Editing Market by CRISPR Services: Other Services, 2021-2031, $ mn 62
Figure 29. Breakdown of North America CRISPR Gene Editing Market by Application, 2021-2031, % of Sales Revenue 64
Figure 30. North America Addressable Market Cap in 2022-2031 by Application, Value ($ mn) and Share (%) 64
Figure 31. North America CRISPR Gene Editing Market by Application: Biomedical Research & Therapy, 2021-2031, $ mn 65
Figure 32. North America CRISPR Gene Editing Market by Biomedical Research & Therapy: Gene Therapy, 2021-2031, $ mn 67
Figure 33. North America CRISPR Gene Editing Market by Biomedical Research & Therapy: Drug Discovery, 2021-2031, $ mn 68
Figure 34. North America CRISPR Gene Editing Market by Biomedical Research & Therapy: Diagnostics, 2021-2031, $ mn 69
Figure 35. North America CRISPR Gene Editing Market by Biomedical Research & Therapy: Other Biomedical Applications, 2021-2031, $ mn 70
Figure 36. North America CRISPR Gene Editing Market by Application: Agriculture, 2021-2031, $ mn 71
Figure 37. North America CRISPR Gene Editing Market by Application: Industrial Use, 2021-2031, $ mn 72
Figure 38. North America CRISPR Gene Editing Market by Application: Other Applications, 2021-2031, $ mn 73
Figure 39. Breakdown of North America CRISPR Gene Editing Market by End User, 2021-2031, % of Sales Revenue 75
Figure 40. North America Addressable Market Cap in 2022-2031 by End User, Value ($ mn) and Share (%) 75
Figure 41. North America CRISPR Gene Editing Market by End User: Pharmaceutical Companies, 2021-2031, $ mn 76
Figure 42. North America CRISPR Gene Editing Market by End User: Biotechnology Companies, 2021-2031, $ mn 77
Figure 43. North America CRISPR Gene Editing Market by End User: Academic Institutions & Research Centers, 2021-2031, $ mn 78
Figure 44. North America CRISPR Gene Editing Market by End User: Other End Users, 2021-2031, $ mn 79
Figure 45. Breakdown of North America CRISPR Gene Editing Market by Country, 2021 and 2031, % of Revenue 81
Figure 46. Contribution to North America 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%) 82
Figure 47. U.S. CRISPR Gene Editing Market, 2021-2031, $ mn 84
Figure 48. Canada CRISPR Gene Editing Market, 2021-2031, $ mn 86
Figure 49. CRISPR Gene Editing Market in Mexico, 2021-2031, $ mn 88
Figure 50. Growth Stage of North America CRISPR Gene Editing Industry over the Forecast Period 90
